Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 22 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

9%

2 trials in Phase 3/4

Results Transparency

0%

0 of 10 completed trials have results

Key Signals

4 recruiting

Enrollment Performance

Analytics

N/A
3(42.9%)
Phase 1
2(28.6%)
Phase 4
2(28.6%)
7Total
N/A(3)
Phase 1(2)
Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (22)

Showing 20 of 22 trials
NCT05750706Completed

Incidence of Invasive Fungal Infections Among Patients With Acute Lymphoblastic Leukemia Ph-negative

Role: collaborator

NCT06700018Recruiting

Flow Patterns and Stent Thrombosis

Role: collaborator

NCT07338071Not Yet Recruiting

Antithrombotic Therapy at the End of Life: The PEACE Study

Role: collaborator

NCT07263880Phase 1Not Yet Recruiting

Clostridium Butyricum in Stenosing Crohn's Desease

Role: lead

NCT03353311Completed

ERAS Lazio Network Clinical Registry

Role: collaborator

NCT06852274Not ApplicableCompleted

Clostridium Butyricum CBM588® vs. Rifaximin for Symptomatic Uncomplicated Diverticular Disease (SUDD): A Real-World Retrospective Study

Role: collaborator

NCT06793280Not ApplicableRecruiting

Evaluation of Colonic Perfusion by Indocyanine Green Angiography During Colorectal Surgery

Role: collaborator

NCT06840990Completed

Cross-linked CMC and Silk Proteins in Corneal Re-epithelization

Role: collaborator

NCT06786663Recruiting

MALE Mamm Organoids

Role: collaborator

NCT06605365Completed

Cross-linked CMC and Silk Proteins in Eye Disease

Role: collaborator

NCT06573606Completed

Ophthalmic Solution in Diabetic Corneal Alteration

Role: collaborator

NCT06240195Recruiting

Biomarkers of Efficacy and Tolerability of Sacituzumab-Govitecan in the Treatment of Patients With Triple-negative Breast Cancer in the Metastatic Phase: Prospective Multicenter Real-world Study

Role: collaborator

NCT06086119Unknown

Quality of Life and Voice Perception in Patients Laryngoctomized Phonatory Wearers

Role: collaborator

NCT04853836Phase 4Completed

Olfactory Disfunction and Co-ultraPEALut

Role: collaborator

NCT04102852Phase 1Completed

Lactobacillus Rhamnosus GG (ATCC 53103) in Mild-moderately Active UC Patients

Role: lead

NCT04949672Completed

Pathology Assessment of Mesorectal Fascia After TME by Laparoscopic, Open, TransAnal and Robotic Approaches (LOTARTME)

Role: lead

NCT02623647Not ApplicableUnknown

A Phase I-II Study on Stereotactic Body Radiotherapy in 3 Fractions for Low/Int Risk Prostate Cancer

Role: collaborator

NCT04689321Unknown

Revision of the EORTC QLQ-BN20 Questionnaire

Role: collaborator

NCT02883088Unknown

Relationship Between OCT Coronary Plaque Morphology and Clinical Outcome

Role: lead

NCT02985112Unknown

INTegrated Assessment of intERmediate Coronary Stenoses by Fractional Flow rEserve (FFR) and Near-infraREd Spectroscopy (NIRS)

Role: collaborator